4.7 Review

Current epidemiological and clinical features of COVID-19; a global perspective from China

Journal

JOURNAL OF INFECTION
Volume 81, Issue 1, Pages 1-9

Publisher

W B SAUNDERS CO LTD
DOI: 10.1016/j.jinf.2020.04.011

Keywords

COVID-19; SARS-CoV-2; 2019-nCoV; Epidemiology; Intervention

Funding

  1. National Natural Science Foundation of China [81701144, 81670567]
  2. Zhejiang Provincial Natural Science Foundation of China [LED20H190 0 03]

Ask authors/readers for more resources

Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and represents a potentially fatal disease of great global public health importance. As of March 26, 2020, the outbreak of COVID-19 has resulted in 462,801 confirmed cases and 20,839 deaths globally, which is more than those caused by SARS and Middle East respiratory syndrome (MERS) in 2003 and 2013, respectively. The epidemic has posed considerable challenges worldwide. Under a strict mechanism of massive prevention and control, China has seen a rapid decrease in new cases of coronavirus; however, the global situation remains serious. Additionally, the origin of COVID-19 has not been determined and no specific antiviral treatment or vaccine is currently available. Based on the published data, this review systematically discusses the etiology, epidemiology, clinical characteristics, and current intervention measures related to COVID-19 in the hope that it may provide a reference for future studies and aid in the prevention and control of the COVID-19 epidemic. (C) 2020 The British Infection Association. Published by Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available